Resolution Medical
Mark A. McCarthy is an experienced program manager currently overseeing product development programs at Resolution Medical since February 2019. Previous roles include serving as a chemist and technical consultant at KRÜSS, where Mark A. McCarthy engaged with clients in surface chemistry and direct sales. Prior experience also includes research chemist positions at Greatbatch Medical and Biomec Incorporated, focusing on biomimetic polymer coatings for clinical applications and various analytical methods. Mark A. McCarthy possesses a strong background in project management, protocol development, and quality assurance, with a Bachelor of Science in Chemistry from Miami University.
Resolution Medical
Founded in 2012, Resolution Medical is a medical device CDMO serving the most demanding interventional therapies, including structural heart, neuromodulation, heart failure, electrophysiology, and oncology. With ISO 13485 and FDA registered facilities, the company’s service offering includes engineering, research, biosimulation, and commercial manufacturing for class I, II, III medical devices including active implantables.